The Chosun Ilbo on MSN

Global pharma, Korean firms race in dementia drug development

U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...
Sinar Daily on MSN

Non-invasive sound therapy boosts hope for Alzheimer's treatment

The study, published in the latest issue of the Proceedings of the National Academy of Sciences (PNAS), was led by ...

Alzheimer’s fighting infusion delivered in Canada for the first time

Sharon Runge has become the first patient in Canadian history to receive an infusion of an Alzheimer’s drug recently approved ...

Scientists Discover Why Promising Alzheimer’s Drugs Keep Failing, and Point to a Fix

Discovery could redirect drug development for disease affecting 6.7 million Americans The two AMPKα isoforms can have ...

Experimental drug reverses Alzheimer's in mice

A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
Science Daily

Study shows young blood can slow Alzheimer’s in mice

New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...